CBRS: Options Turn Defensive as Post-Earnings Rally Accelerates

Cerebras Systems has added 15% in a single session and 46% over the past month, yet options traders have abruptly swung to their most defensive posture on record — a sharp divergence worth unpacking.

The options signal is the standout this week. The put/call ratio jumped to 1.326 on August 17, more than three and a half standard deviations above its 20-day average of 0.78, and the highest reading in CBRS's listed history. For a stock that closed at $251.98 and has been in a sustained uptrend, that level of put demand is unusually elevated. It reads less like conviction in a reversal and more like active hedging by participants who have ridden the rally and are now paying for protection into the next event — the September 22 earnings date.

The borrow market tells a consistent story of extreme constraint, though the specific readings have shifted modestly since the August 12 post-earnings note. Availability has crept up to 1.1% from the prior week's lows near 0.2%, but that remains effectively fully exhausted — roughly one share available for every 90 already lent out. The week-on-week improvement sounds large at 105%, but in absolute terms the pool is still nearly empty. Borrowing costs have continued to ease, falling to 1.6% from a peak above 2.7% in early August, now at their lowest level in six weeks. Short shares outstanding have dipped about 6.5% over the past week to 12.65 million, continuing the trimming trend flagged in the post-earnings note. But this remains a trim, not a retreat — the one-month count is still up roughly 7%, meaning the short base built through July has barely been touched.

Analyst activity clustered heavily around the August 12 print, with firms moving in different directions but all maintaining positive ratings. UBS raised its target to $330, while Citigroup trimmed to $320 from $340 — both keeping Buy calls. Morgan Stanley lifted to $279, Wedbush to $290, and Mizuho edged back to $300 from $310. The consensus mean target is $291.63, roughly 16% above the current price, suggesting the Street broadly sees further room from here even after the month's run. The bull case rests on Cerebras's position in fast AI inference and its OpenAI relationship. The bear case is harder to dismiss: more than 80% of historical revenue came from G42/MBZUAI, and scaling beyond that concentration requires capital-intensive cloud buildout with execution risk attached. The ORTEX short score at 66.9 — down from 68.5 earlier in the month — reflects some easing of bearish signal intensity but remains elevated.

On ownership, the top of the register is still dominated by early-stage holders. FMR holds 12.1% of shares. Foundation Capital and Benchmark each hold around 5-6%. CEO-adjacent figures including co-founder Andrew Feldman hold roughly 6%. The insider data is dated to late June, when the COO sold approximately $2.1 million of stock at prices around $170-$207 — well below the current level — a signal that at least some insiders were trimming into the prior rally phase.

The September 22 earnings date is now the focal point: with the borrow pool still near-exhausted, shorts unable to add meaningfully, the stock up 46% in a month, and puts at a record extreme relative to calls, how the print is received will determine whether that defensive options positioning was well-timed or simply the cost of riding a parabolic move into a catalyst.